SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-028578
Filing Date
2022-05-12
Accepted
2022-05-12 16:38:28
Documents
2
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3128
2 POA DOCUMENT poa.txt EX-24 3070
  Complete submission text file 0001209191-22-028578.txt   7597
Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 6 BEDMINSTER NJ 07921
Business Address
THERO JOHN F (Reporting) CIK: 0001199637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40499 | Film No.: 22918503

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations